Research > Epidemiology, Infectious Diseases and Public Health

Pharmacoepidemiology and Pharmacodynamics (P&P)

Number of publications
245
Publications search

  • Huerva, V; Cid-Bertomeu, P; Espinet, R; Canto, LM

    Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

    Ocular Oncology And Pathology 8 88-92. .

    [doi:10.1159/000522195]

  • Vilaltella, M; Vilardell, F; Cid-Bertomeu, P; Huerva, V

    IgG(4)-related orbital disease

    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 57 78-79. .

  • Rodriguez, AT; Viejo, MN; Maradey, P; Canal-Sotelo, J; Mancilla, PG; Rivero, SG; Casillas, IR; Abian, MH; Bermudo, CL

    Low-dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain in palliative care

    Future Oncology 18 1717-1731. .

    [doi:10.2217/fon-2021-1639]

  • López-Siguero JP; Martínez-Aedo MJ; Bermúdez de la Vega JA; Bosch-Muñoz J; Lechuga-Sancho AM; Villalobos T

    Growth hormone treatment does not to lead to insulin resistance nor excessive rise in IGF-1 levels, while improving height in patients small for gestational age A long-term observational study.

    CLINICAL ENDOCRINOLOGY 96 558-568. .

    [doi:10.1111/cen.14626]

  • Vilaltella, M; Huerva, V

    The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size

    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA 85 109-114. .

    [doi:10.5935/0004-2749.20220018]

  • Martínez-Escardó L; Alemany M; Sánchez-Osuna M; Sánchez-Chardi A; Roig-Martínez M; Suárez-García S; Ruiz-Molina D; Vidal N; Plans G; Majós C; Ribas J; Baltrons MA; Bayascas JR; Barcia C; Bruna J; Yuste VJ

    Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells.

    Cancers 13 -. .

    [doi:10.3390/cancers13215579]

  • Taberner Bonastre P; Torres Vicente G; Cano-Marron M; Sese Abizanda E; Volta Pardo TD; Schoenenberger-Arnaiz JA

    A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib.

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 28 353-355. .

    [doi:10.1136/ejhpharm-2020-002437]

  • Rodriguez, AT; Viejo, MN; Maradey, P; Canal-Sotelo, J; Mancilla, PG; Rivero, SG; Casillas, IR; Abian, MH; Bermudo, CL

    Impact of individualized management of breakthrough cancer pain on quality of life in advanced cancer patients: CAVIDIOPAL study

    SUPPORTIVE CARE IN CANCER 29 4799-4807. .

    [doi:10.1007/s00520-021-06006-1]

  • Huerva, V; Vilaltella, M

    Ocular surface squamous neoplasia resistant to topical interferon alpha 2b in a patient with follicular lymphoma.

    International Journal of Ophthalmology 14 1122-1124. .

    [doi:10.18240/ijo.2021.07.24]

  • Vicent L; Alvarez-Garcia J; Gonzalez-Juanatey JR; Rivera M; Segovia J; Worner F; Bover R; Pascual-Figal D; Vázquez R; Cinca J; Fernandez-Aviles F; Martinez-Sellés M

    Prognostic impact of hyponatremia and hypernatremia at admission and discharge in heart failure patients with preserved, mid-range, and reduced ejection fraction.

    INTERNAL MEDICINE JOURNAL 51 930-938. .

    [doi:10.1111/imj.14836]

  • Coutant, R; Munoz, JB; Dumitrescu, CP; Schnabel, D; Sert, C; Perrot, V; Dattani, M

    Effectiveness and Overall Safety of NutropinAq (R) for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq (R) European Registry (iNCGS)

    Frontiers in Endocrinology 12 676083-676083. .

    [doi:10.3389/fendo.2021.676083]

  • Baena, JMG; Vall, IC; Zielonka, M; Mora, JRM; Godoy, P; Diz, FW

    Risk factors and comorbidities associated with severe aortic stenosis: a case-control study

    REVISTA CLINICA ESPANOLA 221 249-257. .

    [doi:10.1016/j.rce.2020.01.010]